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Abstract: 2-Aminopyridine (2-AP) and 2,6-diaminopyridine (2,6-DAP) are two derivatives of aminopyridines that act as an 
important organic intermediates, mostly used in medicines, dyes and organic sensors. The aim of the study was to evaluate the 
impact of biofield energy treatment on isotopic abundance ratios of 
2
H/
1
H, 
13
C/
12
C, or 
15
N/
14
N, in aminopyridine derivatives 
using gas chromatography-mass spectrometry (GC-MS). The 2-AP and 2,6-DAP samples were divided into two parts: control 
and treated. The control sample remained as untreated, while the treated sample was further divided into four groups as T1, T2, 
T3, and T4. The treated group was subjected to Mr. Trivedi’s biofield energy treatment. The GC-MS spectra of 2-AP and 2,6-
DAP showed five and six m/z peaks respectively due to the molecular ion peak and fragmented peaks of aminopyridine 
derivatives. The isotopic abundance ratio of 
2
H/
1
H, 
13
C/
12
C, or 
15
N/
14
N were calculated for both the derivatives and significant 
alteration was found in the treated samples as compared to the respective control. The isotopic abundance ratio of 
2
H/
1
H, 
13
C/
12
C, or 
15
N/
14
N in treated samples of 2-AP was decreased by 55.83% in T1 and significantly increased by 202.26% in T4. 
However, in case of 2,6-DAP, the isotopic abundance ratio of 
2
H/
1
H, 
13
C/
12
C, and 
15
N/
14
N, in the treated sample showed a 
significant increase (up to 370.54% in T3) with respect to the control. GC-MS data suggested that the biofield energy treatment 
on aminopyridine derivatives had significantly altered the isotopic abundance of 
2
H, 
13
C, or 
15
N in the treated 2-AP and 2,6-
DAP as compared to the control. 
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1. Introduction 
Most of the elements occurred in nature as a mixture of 
isotopes. The relative abundances of isotopes is different at 
different places on the earth and remained constant for years. 
The distribution of contaminant sources of any molecule on a 
native or global scale can be understood by determining the 
isotopic abundance ratio [1]. Any kinetic process that leads to 
the local depletion or enhancement of isotopes in organic 
molecules can be successfully determined using gas 
chromatography-mass spectrometry (GC-MS) [2]. These 
deviations from perfect chemical equivalence are termed as 
isotope effects. The isotopic abundance ratio is commonly 
reported in terms of atom percent and determined by high 
resolution mass spectrometry (HRMS spectrometry) [3]. For 
example, 
13
C 
Atom percent 13C = [13C/(12C+13C)]×100            (1) 
Moreover, the rate of chemical reaction may vary with the 
mass of the nucleus with different isotopic substitutions, 
which slightly affect the partitioning of energy within the 
molecules [4].  
The aminopyridines, selected for this study are heterocyclic 
pharmacophores for many bioactive small organic molecules 
[5]. The growing interest of these molecules 
pharmacologically due to its rare tendency to be oxidized like 
aniline derivatives [6]. Aminopyridines avoid such problems 
due to its reduced oxidation potential, thus make it a safer 
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alternatives for drug design. Additionally, they are 
advantageous because they have exhibited strong absorption 
and emission spectra and thus useful as fluorescent tags while 
investigating the activities on a target [7].  
Aminopyridines are used as a drug for symptomatic 
treatment of multiple sclerosis by blocking potassium 
channels and prolonging action potentials [8, 9]. It has been 
used as intermediate for the synthesis of pharmaceutical 
agents such as piroxicam sulfapyridine, tenoxicam, and 
tripelennamine [6, 10]. Besides, diaminopyridines are mostly 
used for synthesis of dyes, cosmetics, drugs and explosives 
[11, 12]. It is also used as intermediate for the synthesis of 
epoxy curing agents, polyamides, and preparation of 
analgesic phenazo- pyridine hydrochloride [13]. Additionally 
both the aminopyridine derivatives were successfully utilized 
as organic fluorescence sensors for the detection of metal 
cation [14].  
The isotopic abundances of ratios of 
2
H/
1
H, 
13
C/
12
C, or 
15
N/
14
N, could be locally altered by kinetically driven 
chemical reactions. There is an alternative and well-known 
approach, Mr. Trivedi’s biofield energy treatment also known 
as The Trivedi Effect
®
, that can be applied on aminopyridine 
derivatives to undergo the isotopic changes. The 
physicochemical properties of various molecules and crystals 
were already altered by utilizing Mr. Trivedi’s biofield 
energy treatment [15-17]. The National Center for 
Complementary and Alternative Medicine (NCCAM) has 
recommended the use of energy therapy as a part of 
Complementary and alternative medical therapies (CAM) in 
the healthcare sector [18]. CAM includes numerous energy-
healing therapies, in which the biofield therapy is a form of 
putative energy therapy that is being widely used worldwide 
to improve the overall health of human beings. Humans have 
the ability to harness energy from the environment/universe 
that can be transmitted to any objects around.  
Based on the previous results achieved by the biofield 
energy treatments by Mr. Trivedi in various fields, biofield 
energy treated 2-AP and 2,6-DAP were taken for mass 
spectroscopy studies to evaluate the isotopic abundance ratio 
of 
2
H/
1
H, 
13
C/
12
C, or 
15
N/
14
N (PM+1)/PM, [where PM is the 
primary molecule and (PM+1) is isotopic molecule].  
2. Experimental 
2.1. Materials 
Both, 2-aminopyridine (2-AP) and 2,6-diaminopyridine 
(2,6-DAP) were procured from S. D. Fine Chemicals Pvt. 
Limited, India. 
2.2. Method 
Each of the 2-AP and 2,6-DAP sample was distributed into 
two parts, where one part was referred as control and the 
other part was considered as treated sample. The treated 
sample was further divided into four groups (i.e. T1, T2, T3, 
and T4) and handed over to Mr. Trivedi for biofield energy 
treatment under standard laboratory conditions. Mr. Trivedi 
provided the treatment through his energy transmission 
process to the treated groups without touching the sample. 
The control and treated samples were characterized using gas 
chromatography-mass spectrometry (GC-MS).  
2.3. GC-MS Spectroscopy 
The gas chromatography-mass spectroscopy (GC-MS) 
analysis was performed on Perkin Elmer/auto system XL 
with Turbo mass, USA, having detection limit up to 1 
picogram. The GC-MS spectra were obtained in the form 
of % abundance vs. mass to charge ratio (m/z). The isotopic 
abundance ratio (PM+1)/PM was expressed by its deviation 
in treated samples as compared to the control. The percentage 
change in isotopic ratio (PM+1)/PM was calculated from the 
following formula: 
Percent change in isotopic abundance ratio  
   


  100                         (2) 
where, RTreated and RControl are the ratios of intensity at 
(PM+1) to PM in mass spectra of treated and control 
samples, respectively. 
3. Results and Discussion 
3.1. GC-MS Study of 2-AP 
 
Figure 1. GC-MS spectrum of control 2-aminopyridine. 
The GC-MS spectra of control and treated (T1, T2, T3, 
and T4) samples are presented in Fig. 1 and 2, respectively. 
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Mass spectrum of 2-AP is well matched with the reported 
literature [19]. MS spectra showed five peaks including 
molecular ion peak for both the control and treated samples 
of 2-AP. Five major peaks at m/z=94, 67, 51, 41, and 28 were 
observed that corresponded to the following ions 
respectively: C5H6N2
+
, C4H5N
+
, C4H3
+
, C3H5
+
, and C2H4
+ 
ions. The molecular ion peak is the base peak in both control 
and treated samples at m/z=94. The other four peaks were 
observed in both, control and all treated 2-AP samples due to 
the fragmentation of molecular ion inside mass spectrum. 
Further, m/z=67, 51, 41, and 28 peaks were observed might 
be due to first reduction of the molecular ion to pyrrole, 
which again fragmented to give buten-3-yne, propene and 
ethane, respectively. 
The intensity ratio and calculated percentage isotopic 
abundance ratio of all three elements presented in Table 1. 
Moreover, the isotopic abundance ratio (PM+1)/PM in 
control and treated 2-AP was plotted in Fig. 3. 
It was clearly seen from the Table 1 and Fig. 3, that, the 
isotopic abundance ratio of (PM+1)/PM of 2-AP sample was 
decreased in T1 (55.83%) and T2 (25.12%), but increased 
significantly in T3 (117.19%) and T4 (202.26%) after 
biofield energy treatment as compared to the control. The 
decrease in the isotopic abundance ratio of (PM+1)/PM in T1 
and T2 may have nominal effect on the bond energies and 
reactivity of the molecules of treated samples. However, the 
increased isotopic abundance ratio of (PM+1)/PM in T3 and 
T4 may increase the number of higher isotopes (PM+1) in the 
molecule. It may directly affect the bond strength of the C-H, 
N-H and N-C bonds. The increased isotopic abundance ratio 
of (PM+1)/PM in the treated (T3 and T4) sample may 
increase µ (effective mass) and binding energy in the 2-AP 
molecule with heavier isotopes, and this may result in 
enhance binding energy and stability of the molecule [20]. 
Table 1. GC-MS isotopic abundance analysis result of 2-aminopyridine. 
Peak Intensity Control Treated 
  
T1 T2 T3 T4 
m/z of PM 100 100 100 100 100 
m/z of (PM+1) 14.13 6.24 10.58 30.69 42.71 
(PM+1)/ PM 0.141 0.062 0.105 0.306 0.427 
Percent change  -55.83 -25.12 117.19 202.26 
 
Figure 2. GC-MS spectra of treated 2-aminopyridine samples (T1, T2, T3, and T4). 
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Figure 3. Percent change in the isotopic abundance (PM+1)/PM of 2-
aminopyridine after biofield energy treatment as compared to the control. 
3.2. GC-MS Study of 2,6-DAP 
 
Figure 4. GC-MS spectrum of control sample of 2,6-diaminopyridine. 
Mass spectra of both control and treated samples were 
shown in Fig. 4 and 5, respectively. The molecular ion peak 
was observed at m/z=109 in mass spectra of both control and 
treated samples. The calculated relative intensity ratio of 
(PM+1)/PM and percentage abundance ratios are given in 
Table 2. Total five major peaks were observed in the mass 
spectra of both control and treated spectra of 2,6-DAP at 
m/z=109, 82, 66, 55, 39, and 28, corresponded to the 
following ions respectively: C5H7N3
+ 
(PM), C5H8N
+ 
(1,2-
dihydropyridine), C4H4N
+ 
(pyrrole), C4H7
+
 (but-1-ene), C3H3
+
 
(but-1-ene) and C2H4
+
(ethene)
 
ions. In both the molecules 2-
AP and 2,6-DAP, molecular ion peak was observed as a base 
peak. However, they exhibited different fragmentation 
pattern due to the structural and reactivity differences in 
them. The isotopic abundance ratio of (PM+1)/PM of control 
and treated 2,6-DAP was calculated and presented in Fig. 6. 
The isotopic abundance ratio of (PM+1)/PM of treated 2,6-
DAP was increased upto 370.54% in T3 (T1=7.30%, 
T2=40.24%, and T4=12.82%) as compared to the control. 
The mass spectrum of control 2,6-DAP is well supported 
with the reported literature [21]. 
If the lighter isotopes were substituted by heavier isotopes 
then the effective mass (µ) of the particular bond is increased 
and subsequently binding energy will be increased [20]. The 
reverse may also happen if the heavier isotopes, part of the 
chemical bonding were substituted by lighter isotopes in a 
molecule. Thus, the increased isotopic abundance ratio of 
(PM+1)/PM in 2-AP and 2,6-DAP might increase the 
effective mass and binding energy after biofield energy 
treatment that may enhance the chemical stability of 
aminopyridine derivatives. On the contrary, the slight 
decrease in isotopic abundance ratio of (PM+1)/PM in treated 
T1 and T2 in 2-AP might reduce the effective mass of the 
particular bond and binding energy will be decreased. 
Further, the increased (PM+1)/PM will increase the effective 
mass which may decrease the reactivity of the aminopyridine 
derivatives. 
Table 2. GC-MS isotopic abundance analysis result of 2,6-diaminopyridine. 
Peak Intensity Control Treated 
 
 
T1 T2 T3 T4 
m/z of PM 100 100 100 99.8 100 
m/z of (PM+1) 6.71 7.2 9.41 31.51 7.57 
(PM+1)/PM 0.067 0.072 0.094 0.315 0.075 
Percent change  7.30 40.24 370.54 12.82 
Table 3. Possible isotopic bonds in 2-aminopyridine and 2,6-
diaminopyridine. 
Isotopes Bond Isotope type Reduced mass (mAmB /(mA + mB) 
12C-12C Lighter 6.000 
13C-12C Heavier 6.260 
1H-12C Lighter 0.923 
1H-13C Heavier 0.929 
2H-12C Heavier 1.710 
1H-15N Heavier 0.940 
2H-14N Heavier 1.750 
15N-12C Heavier 7.200 
14N-13C heavier 6.500 
15N-13C Heavier 7.170 
Where, mA- mass of atom A, mB- mass of atom B, here A may be C or H 
and so on. 
Effective mass of some probable isotopic bonds were 
calculated and presented in Table 3. The result showed that µ 
of normal 
12
C-
12
C (µ=6), and 
1
H-
12
C (µ=0.923) bonds were 
increased in case of heavier isotopes (i.e. 
13
C-
12
C=6.26, and
 
2
H-
12
C=1.71), respectively. After biofield treatment, bond 
strength, stability, and binding energy of the aromatic ring of 
2-AP and 2,6-DAP molecules might be increased due to the 
higher effective mass (µ) after biofield energy treatment [22]. 
The decreased reactivity of the aminopyridine derivatives 
may increase the stability of the aminopyridine based 
products in pharmaceutical industry, by reducing the 
degradation kinetics in the finished products after production. 
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Furthermore, the organic molecules used for fluorescence 
sensors are exposed to UV radiation continuously for a 
longer period of time. Photo stability is a great concern in 
order to use them successfully as sensors without 
degradation. After biofield treatment the stability may 
enhance due to the presence of higher isotopes an enable 
them to expose the materials under UV radiation for longer 
period [14]. 
 
Figure 5. GC-MS spectra of treated samples of 2,6-diaminopyridine (T1, T2, T3, and T4). 
 
Figure 6. Percent change in the isotopic abundance of (PM+1)/PM of 2,6-
diaminopyridine after biofield energy treatment as compared to the control. 
4. Conclusions 
In summary, aminopyridine derivatives, 2-AP and 2,6-
DAP were studied with GC-MS under the influence of 
biofield energy treatment and observed a significant change 
in isotope abundance of 
2
H/
1
H, 
13
C/
12
C or 
15
N/
14
N as 
compared to the respective control samples. The percent 
change in isotope abundance ratio of (PM+1)/PM was 
increased upto 202.26% in 2-AP (T4), while the isotopic 
abundance ratio was increased significantly upto 370.54 in 
treated 2,6-DAP (T3) sample. The changes in isotopic 
abundance ratios have significant impact on bond energies 
and chemical reactivity of the molecules. Due to the 
enhancement in the isotopic abundance ratio of (PM+1)/PM 
in 2-AP and 2,6-DAP, the reactivity may be reduced 
significantly by increase in the effective mass (µ) and the 
binding energy of the treated sample. It can be concluded 
from the above observations that the enhancement of heavier 
isotopes in the aromatic ring as well as the functional groups 
may decrease the reactivity of the aromatic ring and the 
functional groups of aminopyridine derivatives, consequently 
enabling their utility as pharmacophore in the pharmaceutical 
industry and as an active material in fluorescence sensors. 
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